Latest American Association for Cancer Research Stories
Diverse pipeline compounds target key cancer pathways INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early stage data from several targeted
Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
Company's liquid biopsy technology features single molecule sensitivity and the ability to obtain significantly more circulating tumor DNA (ctDNA) from urine samples vs.
DCVax-L and DCVax-Direct Both To Be the Subject of Presentations Today BETHESDA, Md., April 20, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
NEW DELHI, April 20, 2015 /PRNewswire/ -- - Development of a Novel Taxane and a PI3K Targeting Supramolecular Therapeutic Using the VOLVOX Platform - To be Presented on
$25,000 Awarded to Nikolaus Schultz, PhD for Work on cBioPortal SANTA MONICA, Calif., April 20, 2015 /PRNewswire-USNewswire/ -- The
- On track to file INDs for BLU-285 and initiate clinical studies in mid-2015 - CAMBRIDGE, Mass., April 19, 2015 /PRNewswire/ -- Blueprint Medicines today announced new preclinical data demonstrating
Pembrolizumab Demonstrated 28 Percent Overall Response Rate and 76 Percent Disease Control Rate in Difficult-to-Treat Cancer First Findings from KEYNOTE-028, Merck's Innovative
CAMBRIDGE, England, April 17, 2015 /PRNewswire/ -- Inivata, a Cambridge, England-based clinical cancer genomics company announced today that their presence at the 2015
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for
- A hairdresser.